Pharma-Bio Serv, Inc.
PBSV
$0.42
-$0.16-27.16%
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.83% | -7.13% | -7.87% | -18.82% | 1.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.83% | -7.13% | -7.87% | -18.82% | 1.66% |
| Cost of Revenue | 12.68% | -7.67% | -12.82% | -22.10% | -9.14% |
| Gross Profit | 10.17% | -5.95% | 3.07% | -9.62% | 32.37% |
| SG&A Expenses | -17.40% | -5.04% | 0.17% | -12.69% | -1.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.71% | -6.79% | -8.22% | -18.68% | -6.53% |
| Operating Income | 247.20% | -2.49% | 13.50% | 17.78% | 68.63% |
| Income Before Tax | 137.26% | 276.29% | 129.05% | 27.98% | 152.39% |
| Income Tax Expenses | 16.36% | 227.27% | 114.19% | -125.26% | -74.06% |
| Earnings from Continuing Operations | 144.23% | 287.06% | -100.62% | 33.93% | 144.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 144.23% | 287.06% | -100.62% | 33.93% | 144.62% |
| EBIT | 247.20% | -2.49% | 13.50% | 17.78% | 68.63% |
| EBITDA | 299.12% | 3.74% | 20.72% | 20.97% | 74.18% |
| EPS Basic | 142.86% | 250.00% | -100.00% | 34.07% | 145.16% |
| Normalized Basic EPS | 140.74% | 233.33% | 125.00% | 27.85% | 151.92% |
| EPS Diluted | 150.00% | 150.00% | -100.00% | 35.71% | 143.01% |
| Normalized Diluted EPS | 140.74% | 233.33% | 125.00% | 27.85% | 151.92% |
| Average Basic Shares Outstanding | -0.14% | -0.23% | -0.11% | -0.15% | -0.12% |
| Average Diluted Shares Outstanding | -0.14% | -0.21% | -0.11% | -0.10% | -0.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.59% | -- | -- | -- | 3.24% |